FBIO

MKT CAP:$74M

Fortress Biotech, Inc.

Market Cap

$74M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.23-$1.80 (-44.67%)

Apr 23, 2026

Company Details

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular ...

CEO

Lindsay Allan Rosenwald

IPO Date

Nov 17, 2011

Website

www.fortressbiotech.com

Key Metrics TTM

Revenue

$69M

— YoY

Net Income

-$72M

EPS (Diluted)

-$13.37

Free Cash Flow

-$158M

Revenue / Share

$3.75

Gross Margin

57.9%

Operating Margin

-221.7%

Net Margin

-104.8%

FCF Margin

-230.8%

P/S

1.1x

P/E

—

Earnings Reports

Q3 2024

May 13, 2026

PENDING

Q2 2024

Aug 13, 2024

$15M-14.3%EPS -$0.73

Q4 2023

Mar 28, 2024

$20M+21.6%EPS -$1.19

Q2 2023

Aug 14, 2023

$17MEPS -$3.65

Q4 2022

Mar 31, 2023

$16MEPS -$7.80

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 22	$16M	$8M	-$55M
Q2 23	$17M	$10M	-$50M
Q4 23	$20M	$14M	-$20M
Q2 24	$15M	$8M	-$28M

Valuation

Quarter	P/S	P/E
Q4 22	—	—
Q2 23	—	—
Q4 23	—	—
Q2 24	0.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$48M	-$68M
Q2 23	-$33M	-$33M
Q4 23	-$35M	-$35M
Q2 24	-$22M	-$22M

Capital Expenditures

Quarter	CapEx
Q4 22	$20M
Q2 23	$34.0K
Q4 23	$63.0K
Q2 24	$0

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	0.0%
Q2 23	$0	0.0%
Q4 23	$4M	18.6%
Q2 24	$5M	33.6%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 22	$35M	$27M
Q2 23	$32M	$24M
Q4 23	$14M	$23M
Q2 24	$13M	$21M

Revenue Segments

Quarter	Accutane	Amzeeq	Exelderm	Qbrexza	Targadox	Ximino	Zilxi
Q4 22	$4M	$1M	$445.0K	$7M	$1M	$1M	$422.0K
Q2 23	$6M	$1M	$538.0K	$8M	$664.0K	$155.0K	$572.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$288M	$0	$288M
Q2 22	$249M	$0	$249M
Q3 22	$208M	$0	$208M
Q4 22	$178M	$0	$178M
Q1 23	$152M	$0	$152M
Q2 23	$87M	$0	$87M
Q3 23	$75M	$0	$75M
Q4 23	$81M	$0	$81M
Q1 24	$86M	$0	$86M
Q2 24	$76M	$0	$76M
Q3 24	$59M	$0	$59M
Q4 24	$57M	$0	$57M
Q1 25	$91M	$0	$91M
Q2 25	$74M	$0	$74M
Q3 25	$86M	$0	$86M
Q4 25	$79M	$0	$79M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 22	6M	—	—
Q2 23	7M	+22.1%	—
Q4 23	8M	+5.8%	—
Q2 24	18M	+134.7%	—

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 22	$87.7K	187
Q2 23	$93.0K	187
Q4 23	$107.2K	186
Q2 24	$80.1K	186

Revenue / Employee